| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |